share_log

天大藥業:(I)與上藥修訂現有持續關連交易之年度上限;(II)與上藥重續框架協議;及(III)股東特別大會通告

TIANDA PHARMA: (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH; (II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH; AND (III) NOTICE OF EXTRAORDINARY GENERAL MEETING

香港交易所 ·  Oct 18, 2023 04:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more